US 10279038
Agonist antibodies that bind human CD137 and uses thereof
granted A61KA61K2039/572A61K35/17
Quick answer
US patent 10279038 (Agonist antibodies that bind human CD137 and uses thereof) held by Compass Therapeutics LLC expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/572, A61K35/17, A61K39/001117, A61K39/39558